Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021177

CHIEF ACCOUNTING OFFICER sold 17,000 shares at $32.35 ($549,950)

  • CHIEF ACCOUNTING OFFICER acquired 17,000 shares (option exercise)
  • CHIEF ACCOUNTING OFFICER acquired 495 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-07-15 Grant or award 10b5-1 +495 $15.63 $7,737 33,041 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-08-04 Option exercise 10b5-1 +17,000 $15.52 $263,840 50,041 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-08-04 Sale 10b5-1 −17,000 $32.35 $549,950 33,041 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2025-08-04 Option exercise · Share Option 10b5-1 −17,000 0 D
Open-market sales · 17,000 sh · avg $32.35 · $549,950
Loading xslF345X05/form4-08062025_040801.xml…